Skip to content

Cryotherapy Versus Standard Care in Reducing Opioid Consumption After Total Knee Arthroplasty

Efficacy of Cryotherapy Versus Standard Care in Reducing Opioid Consumption After Total Knee Arthroplasty: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07630337
Enrollment
74
Registered
2026-06-05
Start date
2026-02-01
Completion date
2027-06-01
Last updated
2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee, Postoperative Pain, Total Knee Arthroplasty

Brief summary

The goal of this clinical trial is to learn if compressive cryotherapy can reduce postoperative opioid consumption in patients undergoing primary total knee arthroplasty. It will also evaluate whether compressive cryotherapy improves postoperative recovery compared with standard care using conventional ice application. The main questions it aims to answer are: Does compressive cryotherapy reduce the total consumption of opioids during the first 7 days after total knee arthroplasty? Does compressive cryotherapy reduce postoperative pain and improve early recovery compared with standard cryotherapy? Researchers will compare compressive cryotherapy using the Game Ready® device with standard care using traditional ice packs to determine whether the intervention reduces opioid consumption and improves postoperative outcomes. Participants will: Be randomly assigned to receive compressive cryotherapy or standard cryotherapy with ice packs after surgery. Apply the assigned treatment four times per day during the first 7 postoperative days. Record daily pain levels using a visual analog scale (VAS) and document opioid consumption in a pain diary. Attend a follow-up visit on postoperative day 7 for evaluation of knee swelling, hematoma size, and recovery using the QoR-15 questionnaire.

Interventions

DEVICEGame Ready® compressive cryotherapy device

The Game Ready® system provides continuous cold water circulation combined with intermittent pneumatic compression using a circumferential wrap applied to the operated knee. The device will be used for 20 minutes per session, four times per day during the first 7 postoperative days after total knee arthroplasty.

OTHERStandard cryotherapy (ice packs)

Conventional cryotherapy consisting of ice packs applied to the operated knee after surgery according to standard postoperative care. Ice packs will be applied intermittently during the first 7 postoperative days.

Sponsors

Hospital Italiano de Buenos Aires
Lead SponsorOTHER
Avanos Medical
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

This is an open-label trial. Due to the nature of the intervention (compressive cryotherapy device versus conventional ice application), masking of participants and care providers is not feasible.

Intervention model description

This is a randomized parallel-group clinical trial with a 1:1 allocation ratio comparing compressive cryotherapy using the Game Ready® device with standard care using conventional ice packs in patients undergoing primary total knee arthroplasty. Participants will receive the assigned intervention during the first 7 postoperative days.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age between 60 and 80 years * Scheduled to undergo primary total knee arthroplasty for knee osteoarthritis * Ability to understand the study procedures and provide written informed consent

Exclusion criteria

* Revision total knee arthroplasty * Vascular disorders affecting the lower limbs * Body mass index (BMI) greater than 35 kg/m² * Active knee infection * Severe preoperative limitations in knee mobility

Design outcomes

Primary

MeasureTime frameDescription
Total opioid consumption (tramadol tablets)First 7 days after surgeryTotal number of tramadol tablets (50 mg each) consumed by participants during the first 7 postoperative days after primary total knee arthroplasty. Participants will record daily tramadol consumption in a pain diary, and the total number of tablets used during the study period will be calculated.

Secondary

MeasureTime frameDescription
Postoperative pain intensity measured using the Visual Analog Scale (VAS)Daily during the first 7 days after surgeryPain intensity will be assessed using a 0-10 Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain. Participants will record daily pain scores in a pain diary during the first postoperative week.
Knee swelling measured by limb circumferenceBaseline (preoperative) and postoperative day 7Postoperative swelling will be assessed by measuring limb circumference 10 cm proximal to the superior pole of the patella and 10 cm distal to the inferior pole of the patella. Measurements will be compared with preoperative baseline values.
Hematoma sizePostoperative day 7Hematoma size at the surgical site will be assessed on postoperative day 7 using the Fagotti square classification method and recorded in square centimeters.
Quality of recovery measured with the QoR-15 questionnairePostoperative day 7Patient-reported quality of recovery will be assessed using the validated Quality of Recovery-15 (QoR-15) questionnaire, which evaluates physical comfort, emotional state, physical independence, psychological support, and pain. Scores range from 0 to 150, with higher scores indicating better recovery.

Countries

Argentina

Contacts

CONTACTIvan Huespe, MD
ivan.huespe@hospitalitaliano.org.ar+543425382554
STUDY_CHAIRIvan A Huespe, MD

Hospital Italiano de Buenos Aires

PRINCIPAL_INVESTIGATORIgancio Garcia Mansilla, MD

Hospital Italiano de Buenos Aires

STUDY_DIRECTORMatias Costa Paz, MD

Hospital Italiano de Buenos Aires

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026